Back

Sarcomere gene variants did not improve cardiac function in pediatric patients with dilated cardiomyopathy from Japanese cohorts

Hirono, K.; Hata, Y.; Ichimata, S.; Nishida, N.; Imamura, T.; Asano, Y.; Kuramoto, Y.; Tsuboi, K.; Takarada, S.; Okabe, M.; Nakaoka, H.; Ibuki, K.; Ozawa, S.; Muneuch, J.; Yasuda, K.; Urayama, K.; Oka, H.; Miyamoto, T.; Baba, K.; Kato, A.; Saiki, H.; Kuwahara, N.; Harada, M.; Baba, S.; Morikawa, M.; Iwasaki, H.; Hirata, Y.; Ito, Y.; Sakaguchi, H.; Urata, S.; Toda, K.; Kittaka, E.; Okada, S.; Hasebe, Y.; hoshino, s.; Fujii, T.; Mitsushita, N.; Nii, M.; Ogino, K.; Fujino, M.; Yoshida, Y.; Fukuda, Y.; Iwashima, S.; Takigiku, K.; Sakata, Y.; Inuzuka, R.; Maeda, J.; Hayabuchi, Y.; Fujioka, T.; Nami

2024-01-28 pediatrics
10.1101/2024.01.24.24301754 medRxiv
Show abstract

BackgroundDilated cardiomyopathy (DCM) is a progressive myocardial disorder characterized by impaired cardiac contraction and ventricular dilation. Some patients with DCM could manifest improvement in these abnormalities called left ventricular reverse remodeling (LVRR). However, the detailed association between genotypes and clinical outcomes, including LVRR, particularly among pediatric patients, remains uncertain. MethodsWe prospectively enrolled pediatric patients with DCM from Japanese multi-institutional centers between 2014 and 2023. We identified DCM-related genes and explored the association between gene variants and clinical outcomes, including LVRR, which was defined as any increase in left ventricular ejection fraction during the observation period. ResultsA total of 123 pediatric patients (62 males; mean age of 8 months [range, 1-51 months]) were retrospectively enrolled. There were 50 pathogenic variants in 45 patients (35.0%). The most identified gene was MYH7 (14.0%), followed by RYR2 (12.0%), and TPM1 (8.0%). A novel variant in the CASZ1 gene (NM_001079843.2 c.3356G>A, p. Trp1119Ter) was identified. LVRR was achieved in 47.5% of patients. In patients with sarcomere gene variants, the left ventricular ejection fraction remained unchanged (31.4% to 39.8%, P = 0.1913), whereas it significantly increased in patients with non-sarcomere gene variants (33.4% to 47.8%, P = 0.0466) and in patients without gene variants (33.6% to 54.1%, P = 0.003). ConclusionsPediatric patients with DCM exhibited a marked genetic heterogeneity with a different landscape from adults with DCM. LVRR was not uniform across functional gene groups, opening the door to tailor-made gene-guided prediction in pediatric patients with DCM. Clinical perspectiveO_ST_ABSWhat is new?C_ST_ABSO_LIYounger patients had predominance for DCM and risk factors for survival. C_LIO_LILVRR occurrence was lower in the sarcomere gene group, and cardiac function failed to improve. C_LI What are the clinical implications?O_LILVRR was not uniform across functional gene groups, which opens the door to the adoption of an individualized prediction approach in DCM according to the genetic features. C_LI

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.